Sponsor:
Yale University
Code:
NCT05753059
Conditions
Heart Failure
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Placebo
Amiloride
Bendroflumethiazide
Brief summary:
Conditions
Heart Failure
Study ID
NCT05753059
Start date
Aug 10, 2023
Status verified date
Sep, 2026
Completion date
Jun 1, 2028
Anticipated
Primary completion date
Jun 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Other
Arms
placebo comparator: Placebo/ Placebo
active comparator: Placebo/ Amiloride
active comparator: Placebo/ Bendroflumethiazide
active comparator: Bendroflumethiazide/ Amiloride
Interventions
Placebo
Amiloride
Bendroflumethiazide
Primary outcome measure
Central contacts
Locations
Yale University
Recruiting
New Haven, Connecticut, United States, 06510
Sponsor
Yale University
Last update posted
Sep 8, 2026
Last verified
Sep, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Yale University on 2026-09-08.